Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclo 3 Fort vs MPFF in Chronic Venous Disease
NCT02907320Phase 2Withdrawn
- Sponsor
- Pierre Fabre Laboratories
- Start
- Dec 2016
- Primary completion
- May 2018
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ruscus extract + hesperidin methyl chalcone + ascorbic acid in chronic venous disease (CVD), sponsored by Pierre Fabre Laboratories. Planned start Dec 2016; status: withdrawn.
02
Drugs
ruscus extract + hesperidin methyl chalcone + ascorbic acid
03
Conditions
chronic venous disease (CVD)
Beyond the preview
Go deeper on NCT02907320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02907320.